Global Pril-series Drugs Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Pril-series drugs are one of the commonly used antihypertensive drugs in clinical practice, ending with 'Pril', such as perindopril and enalapril. Pril-series drugs are called Angiotensin-converting enzyme (ACE) inhibitors, are medicines that help relax the veins and arteries to lower blood pressure. ACE inhibitors prevent an enzyme in the body from making angiotensin 2, a substance that narrows blood vessels. This narrowing can cause high blood pressure and forces the heart to work harder.
The global Pril-series Drugs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Pril-series Drugs Industry Forecast” looks at past sales and reviews total world Pril-series Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Pril-series Drugs sales for 2023 through 2029. With Pril-series Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pril-series Drugs industry.
This Insight Report provides a comprehensive analysis of the global Pril-series Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pril-series Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pril-series Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pril-series Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pril-series Drugs.
United States market for Pril-series Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Pril-series Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Pril-series Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Pril-series Drugs players cover Servier, Sanofi, Novartis, Bristol-Myers Squibb Company, Pfizer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Pril-series Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
Pril-series drugs are one of the commonly used antihypertensive drugs in clinical practice, ending with 'Pril', such as perindopril and enalapril. Pril-series drugs are called Angiotensin-converting enzyme (ACE) inhibitors, are medicines that help relax the veins and arteries to lower blood pressure. ACE inhibitors prevent an enzyme in the body from making angiotensin 2, a substance that narrows blood vessels. This narrowing can cause high blood pressure and forces the heart to work harder.
The global Pril-series Drugs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Pril-series Drugs Industry Forecast” looks at past sales and reviews total world Pril-series Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Pril-series Drugs sales for 2023 through 2029. With Pril-series Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pril-series Drugs industry.
This Insight Report provides a comprehensive analysis of the global Pril-series Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pril-series Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pril-series Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pril-series Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pril-series Drugs.
United States market for Pril-series Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Pril-series Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Pril-series Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Pril-series Drugs players cover Servier, Sanofi, Novartis, Bristol-Myers Squibb Company, Pfizer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Pril-series Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Enalapril
- Lisinopril
- Captopril
- Ramipril
- Perindopril
- Others
- Hospital Pharmaty
- Retail Pharmacy
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Enalapril
- Lisinopril
- Captopril
- Ramipril
- Perindopril
- Others
- Hospital Pharmaty
- Retail Pharmacy
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Servier
- Sanofi
- Novartis
- Bristol-Myers Squibb Company
- Pfizer
- TAD Pharma
- Organon Pharma
- Huahai Pharmaceutical
- Kunshan Rotam Reddy Pharmaceutical
- Shenzhen Salubris Pharmaceuticals
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pril-series Drugs Market Size 2019-2030
2.1.2 Pril-series Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Pril-series Drugs by Country/Region, 2019, 2023 & 2030
2.2 Pril-series Drugs Segment by Type
2.2.1 Enalapril
2.2.2 Lisinopril
2.2.3 Captopril
2.2.4 Ramipril
2.2.5 Perindopril
2.2.6 Others
2.3 Pril-series Drugs Market Size by Type
2.3.1 Pril-series Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Pril-series Drugs Market Size Market Share by Type (2019-2024)
2.4 Pril-series Drugs Segment by Application
2.4.1 Hospital Pharmaty
2.4.2 Retail Pharmacy
2.5 Pril-series Drugs Market Size by Application
2.5.1 Pril-series Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Pril-series Drugs Market Size Market Share by Application (2019-2024)
3 PRIL-SERIES DRUGS MARKET SIZE BY PLAYER
3.1 Pril-series Drugs Market Size Market Share by Player
3.1.1 Global Pril-series Drugs Revenue by Player (2019-2024)
3.1.2 Global Pril-series Drugs Revenue Market Share by Player (2019-2024)
3.2 Global Pril-series Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PRIL-SERIES DRUGS BY REGION
4.1 Pril-series Drugs Market Size by Region (2019-2024)
4.2 Global Pril-series Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Pril-series Drugs Market Size Growth (2019-2024)
4.4 APAC Pril-series Drugs Market Size Growth (2019-2024)
4.5 Europe Pril-series Drugs Market Size Growth (2019-2024)
4.6 Middle East & Africa Pril-series Drugs Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Pril-series Drugs Market Size by Country (2019-2024)
5.2 Americas Pril-series Drugs Market Size by Type (2019-2024)
5.3 Americas Pril-series Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pril-series Drugs Market Size by Region (2019-2024)
6.2 APAC Pril-series Drugs Market Size by Type (2019-2024)
6.3 APAC Pril-series Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Pril-series Drugs Market Size by Country (2019-2024)
7.2 Europe Pril-series Drugs Market Size by Type (2019-2024)
7.3 Europe Pril-series Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pril-series Drugs by Region (2019-2024)
8.2 Middle East & Africa Pril-series Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Pril-series Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PRIL-SERIES DRUGS MARKET FORECAST
10.1 Global Pril-series Drugs Forecast by Region (2025-2030)
10.1.1 Global Pril-series Drugs Forecast by Region (2025-2030)
10.1.2 Americas Pril-series Drugs Forecast
10.1.3 APAC Pril-series Drugs Forecast
10.1.4 Europe Pril-series Drugs Forecast
10.1.5 Middle East & Africa Pril-series Drugs Forecast
10.2 Americas Pril-series Drugs Forecast by Country (2025-2030)
10.2.1 United States Market Pril-series Drugs Forecast
10.2.2 Canada Market Pril-series Drugs Forecast
10.2.3 Mexico Market Pril-series Drugs Forecast
10.2.4 Brazil Market Pril-series Drugs Forecast
10.3 APAC Pril-series Drugs Forecast by Region (2025-2030)
10.3.1 China Pril-series Drugs Market Forecast
10.3.2 Japan Market Pril-series Drugs Forecast
10.3.3 Korea Market Pril-series Drugs Forecast
10.3.4 Southeast Asia Market Pril-series Drugs Forecast
10.3.5 India Market Pril-series Drugs Forecast
10.3.6 Australia Market Pril-series Drugs Forecast
10.4 Europe Pril-series Drugs Forecast by Country (2025-2030)
10.4.1 Germany Market Pril-series Drugs Forecast
10.4.2 France Market Pril-series Drugs Forecast
10.4.3 UK Market Pril-series Drugs Forecast
10.4.4 Italy Market Pril-series Drugs Forecast
10.4.5 Russia Market Pril-series Drugs Forecast
10.5 Middle East & Africa Pril-series Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Market Pril-series Drugs Forecast
10.5.2 South Africa Market Pril-series Drugs Forecast
10.5.3 Israel Market Pril-series Drugs Forecast
10.5.4 Turkey Market Pril-series Drugs Forecast
10.6 Global Pril-series Drugs Forecast by Type (2025-2030)
10.7 Global Pril-series Drugs Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Pril-series Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Servier
11.1.1 Servier Company Information
11.1.2 Servier Pril-series Drugs Product Offered
11.1.3 Servier Pril-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Servier Main Business Overview
11.1.5 Servier Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Pril-series Drugs Product Offered
11.2.3 Sanofi Pril-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Pril-series Drugs Product Offered
11.3.3 Novartis Pril-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Bristol-Myers Squibb Company
11.4.1 Bristol-Myers Squibb Company Company Information
11.4.2 Bristol-Myers Squibb Company Pril-series Drugs Product Offered
11.4.3 Bristol-Myers Squibb Company Pril-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Bristol-Myers Squibb Company Main Business Overview
11.4.5 Bristol-Myers Squibb Company Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Pril-series Drugs Product Offered
11.5.3 Pfizer Pril-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 TAD Pharma
11.6.1 TAD Pharma Company Information
11.6.2 TAD Pharma Pril-series Drugs Product Offered
11.6.3 TAD Pharma Pril-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 TAD Pharma Main Business Overview
11.6.5 TAD Pharma Latest Developments
11.7 Organon Pharma
11.7.1 Organon Pharma Company Information
11.7.2 Organon Pharma Pril-series Drugs Product Offered
11.7.3 Organon Pharma Pril-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Organon Pharma Main Business Overview
11.7.5 Organon Pharma Latest Developments
11.8 Huahai Pharmaceutical
11.8.1 Huahai Pharmaceutical Company Information
11.8.2 Huahai Pharmaceutical Pril-series Drugs Product Offered
11.8.3 Huahai Pharmaceutical Pril-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Huahai Pharmaceutical Main Business Overview
11.8.5 Huahai Pharmaceutical Latest Developments
11.9 Kunshan Rotam Reddy Pharmaceutical
11.9.1 Kunshan Rotam Reddy Pharmaceutical Company Information
11.9.2 Kunshan Rotam Reddy Pharmaceutical Pril-series Drugs Product Offered
11.9.3 Kunshan Rotam Reddy Pharmaceutical Pril-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Kunshan Rotam Reddy Pharmaceutical Main Business Overview
11.9.5 Kunshan Rotam Reddy Pharmaceutical Latest Developments
11.10 Shenzhen Salubris Pharmaceuticals
11.10.1 Shenzhen Salubris Pharmaceuticals Company Information
11.10.2 Shenzhen Salubris Pharmaceuticals Pril-series Drugs Product Offered
11.10.3 Shenzhen Salubris Pharmaceuticals Pril-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Shenzhen Salubris Pharmaceuticals Main Business Overview
11.10.5 Shenzhen Salubris Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pril-series Drugs Market Size 2019-2030
2.1.2 Pril-series Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Pril-series Drugs by Country/Region, 2019, 2023 & 2030
2.2 Pril-series Drugs Segment by Type
2.2.1 Enalapril
2.2.2 Lisinopril
2.2.3 Captopril
2.2.4 Ramipril
2.2.5 Perindopril
2.2.6 Others
2.3 Pril-series Drugs Market Size by Type
2.3.1 Pril-series Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Pril-series Drugs Market Size Market Share by Type (2019-2024)
2.4 Pril-series Drugs Segment by Application
2.4.1 Hospital Pharmaty
2.4.2 Retail Pharmacy
2.5 Pril-series Drugs Market Size by Application
2.5.1 Pril-series Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Pril-series Drugs Market Size Market Share by Application (2019-2024)
3 PRIL-SERIES DRUGS MARKET SIZE BY PLAYER
3.1 Pril-series Drugs Market Size Market Share by Player
3.1.1 Global Pril-series Drugs Revenue by Player (2019-2024)
3.1.2 Global Pril-series Drugs Revenue Market Share by Player (2019-2024)
3.2 Global Pril-series Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PRIL-SERIES DRUGS BY REGION
4.1 Pril-series Drugs Market Size by Region (2019-2024)
4.2 Global Pril-series Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Pril-series Drugs Market Size Growth (2019-2024)
4.4 APAC Pril-series Drugs Market Size Growth (2019-2024)
4.5 Europe Pril-series Drugs Market Size Growth (2019-2024)
4.6 Middle East & Africa Pril-series Drugs Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Pril-series Drugs Market Size by Country (2019-2024)
5.2 Americas Pril-series Drugs Market Size by Type (2019-2024)
5.3 Americas Pril-series Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pril-series Drugs Market Size by Region (2019-2024)
6.2 APAC Pril-series Drugs Market Size by Type (2019-2024)
6.3 APAC Pril-series Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Pril-series Drugs Market Size by Country (2019-2024)
7.2 Europe Pril-series Drugs Market Size by Type (2019-2024)
7.3 Europe Pril-series Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pril-series Drugs by Region (2019-2024)
8.2 Middle East & Africa Pril-series Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Pril-series Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PRIL-SERIES DRUGS MARKET FORECAST
10.1 Global Pril-series Drugs Forecast by Region (2025-2030)
10.1.1 Global Pril-series Drugs Forecast by Region (2025-2030)
10.1.2 Americas Pril-series Drugs Forecast
10.1.3 APAC Pril-series Drugs Forecast
10.1.4 Europe Pril-series Drugs Forecast
10.1.5 Middle East & Africa Pril-series Drugs Forecast
10.2 Americas Pril-series Drugs Forecast by Country (2025-2030)
10.2.1 United States Market Pril-series Drugs Forecast
10.2.2 Canada Market Pril-series Drugs Forecast
10.2.3 Mexico Market Pril-series Drugs Forecast
10.2.4 Brazil Market Pril-series Drugs Forecast
10.3 APAC Pril-series Drugs Forecast by Region (2025-2030)
10.3.1 China Pril-series Drugs Market Forecast
10.3.2 Japan Market Pril-series Drugs Forecast
10.3.3 Korea Market Pril-series Drugs Forecast
10.3.4 Southeast Asia Market Pril-series Drugs Forecast
10.3.5 India Market Pril-series Drugs Forecast
10.3.6 Australia Market Pril-series Drugs Forecast
10.4 Europe Pril-series Drugs Forecast by Country (2025-2030)
10.4.1 Germany Market Pril-series Drugs Forecast
10.4.2 France Market Pril-series Drugs Forecast
10.4.3 UK Market Pril-series Drugs Forecast
10.4.4 Italy Market Pril-series Drugs Forecast
10.4.5 Russia Market Pril-series Drugs Forecast
10.5 Middle East & Africa Pril-series Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Market Pril-series Drugs Forecast
10.5.2 South Africa Market Pril-series Drugs Forecast
10.5.3 Israel Market Pril-series Drugs Forecast
10.5.4 Turkey Market Pril-series Drugs Forecast
10.6 Global Pril-series Drugs Forecast by Type (2025-2030)
10.7 Global Pril-series Drugs Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Pril-series Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Servier
11.1.1 Servier Company Information
11.1.2 Servier Pril-series Drugs Product Offered
11.1.3 Servier Pril-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Servier Main Business Overview
11.1.5 Servier Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Pril-series Drugs Product Offered
11.2.3 Sanofi Pril-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Pril-series Drugs Product Offered
11.3.3 Novartis Pril-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Bristol-Myers Squibb Company
11.4.1 Bristol-Myers Squibb Company Company Information
11.4.2 Bristol-Myers Squibb Company Pril-series Drugs Product Offered
11.4.3 Bristol-Myers Squibb Company Pril-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Bristol-Myers Squibb Company Main Business Overview
11.4.5 Bristol-Myers Squibb Company Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Pril-series Drugs Product Offered
11.5.3 Pfizer Pril-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 TAD Pharma
11.6.1 TAD Pharma Company Information
11.6.2 TAD Pharma Pril-series Drugs Product Offered
11.6.3 TAD Pharma Pril-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 TAD Pharma Main Business Overview
11.6.5 TAD Pharma Latest Developments
11.7 Organon Pharma
11.7.1 Organon Pharma Company Information
11.7.2 Organon Pharma Pril-series Drugs Product Offered
11.7.3 Organon Pharma Pril-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Organon Pharma Main Business Overview
11.7.5 Organon Pharma Latest Developments
11.8 Huahai Pharmaceutical
11.8.1 Huahai Pharmaceutical Company Information
11.8.2 Huahai Pharmaceutical Pril-series Drugs Product Offered
11.8.3 Huahai Pharmaceutical Pril-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Huahai Pharmaceutical Main Business Overview
11.8.5 Huahai Pharmaceutical Latest Developments
11.9 Kunshan Rotam Reddy Pharmaceutical
11.9.1 Kunshan Rotam Reddy Pharmaceutical Company Information
11.9.2 Kunshan Rotam Reddy Pharmaceutical Pril-series Drugs Product Offered
11.9.3 Kunshan Rotam Reddy Pharmaceutical Pril-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Kunshan Rotam Reddy Pharmaceutical Main Business Overview
11.9.5 Kunshan Rotam Reddy Pharmaceutical Latest Developments
11.10 Shenzhen Salubris Pharmaceuticals
11.10.1 Shenzhen Salubris Pharmaceuticals Company Information
11.10.2 Shenzhen Salubris Pharmaceuticals Pril-series Drugs Product Offered
11.10.3 Shenzhen Salubris Pharmaceuticals Pril-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Shenzhen Salubris Pharmaceuticals Main Business Overview
11.10.5 Shenzhen Salubris Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pril-series Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Pril-series Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Enalapril
Table 4. Major Players of Lisinopril
Table 5. Major Players of Captopril
Table 6. Major Players of Ramipril
Table 7. Major Players of Perindopril
Table 8. Major Players of Others
Table 9. Pril-series Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 10. Global Pril-series Drugs Market Size by Type (2019-2024) & ($ millions)
Table 11. Global Pril-series Drugs Market Size Market Share by Type (2019-2024)
Table 12. Pril-series Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 13. Global Pril-series Drugs Market Size by Application (2019-2024) & ($ millions)
Table 14. Global Pril-series Drugs Market Size Market Share by Application (2019-2024)
Table 15. Global Pril-series Drugs Revenue by Player (2019-2024) & ($ millions)
Table 16. Global Pril-series Drugs Revenue Market Share by Player (2019-2024)
Table 17. Pril-series Drugs Key Players Head office and Products Offered
Table 18. Pril-series Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Pril-series Drugs Market Size by Region (2019-2024) & ($ millions)
Table 22. Global Pril-series Drugs Market Size Market Share by Region (2019-2024)
Table 23. Global Pril-series Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 24. Global Pril-series Drugs Revenue Market Share by Country/Region (2019-2024)
Table 25. Americas Pril-series Drugs Market Size by Country (2019-2024) & ($ millions)
Table 26. Americas Pril-series Drugs Market Size Market Share by Country (2019-2024)
Table 27. Americas Pril-series Drugs Market Size by Type (2019-2024) & ($ millions)
Table 28. Americas Pril-series Drugs Market Size Market Share by Type (2019-2024)
Table 29. Americas Pril-series Drugs Market Size by Application (2019-2024) & ($ millions)
Table 30. Americas Pril-series Drugs Market Size Market Share by Application (2019-2024)
Table 31. APAC Pril-series Drugs Market Size by Region (2019-2024) & ($ millions)
Table 32. APAC Pril-series Drugs Market Size Market Share by Region (2019-2024)
Table 33. APAC Pril-series Drugs Market Size by Type (2019-2024) & ($ millions)
Table 34. APAC Pril-series Drugs Market Size by Application (2019-2024) & ($ millions)
Table 35. Europe Pril-series Drugs Market Size by Country (2019-2024) & ($ millions)
Table 36. Europe Pril-series Drugs Market Size Market Share by Country (2019-2024)
Table 37. Europe Pril-series Drugs Market Size by Type (2019-2024) & ($ millions)
Table 38. Europe Pril-series Drugs Market Size by Application (2019-2024) & ($ millions)
Table 39. Middle East & Africa Pril-series Drugs Market Size by Region (2019-2024) & ($ millions)
Table 40. Middle East & Africa Pril-series Drugs Market Size by Type (2019-2024) & ($ millions)
Table 41. Middle East & Africa Pril-series Drugs Market Size by Application (2019-2024) & ($ millions)
Table 42. Key Market Drivers & Growth Opportunities of Pril-series Drugs
Table 43. Key Market Challenges & Risks of Pril-series Drugs
Table 44. Key Industry Trends of Pril-series Drugs
Table 45. Global Pril-series Drugs Market Size Forecast by Region (2025-2030) & ($ millions)
Table 46. Global Pril-series Drugs Market Size Market Share Forecast by Region (2025-2030)
Table 47. Global Pril-series Drugs Market Size Forecast by Type (2025-2030) & ($ millions)
Table 48. Global Pril-series Drugs Market Size Forecast by Application (2025-2030) & ($ millions)
Table 49. Servier Details, Company Type, Pril-series Drugs Area Served and Its Competitors
Table 50. Servier Pril-series Drugs Product Offered
Table 51. Servier Pril-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 52. Servier Main Business
Table 53. Servier Latest Developments
Table 54. Sanofi Details, Company Type, Pril-series Drugs Area Served and Its Competitors
Table 55. Sanofi Pril-series Drugs Product Offered
Table 56. Sanofi Pril-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Sanofi Main Business
Table 58. Sanofi Latest Developments
Table 59. Novartis Details, Company Type, Pril-series Drugs Area Served and Its Competitors
Table 60. Novartis Pril-series Drugs Product Offered
Table 61. Novartis Pril-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Novartis Main Business
Table 63. Novartis Latest Developments
Table 64. Bristol-Myers Squibb Company Details, Company Type, Pril-series Drugs Area Served and Its Competitors
Table 65. Bristol-Myers Squibb Company Pril-series Drugs Product Offered
Table 66. Bristol-Myers Squibb Company Pril-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Bristol-Myers Squibb Company Main Business
Table 68. Bristol-Myers Squibb Company Latest Developments
Table 69. Pfizer Details, Company Type, Pril-series Drugs Area Served and Its Competitors
Table 70. Pfizer Pril-series Drugs Product Offered
Table 71. Pfizer Pril-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Pfizer Main Business
Table 73. Pfizer Latest Developments
Table 74. TAD Pharma Details, Company Type, Pril-series Drugs Area Served and Its Competitors
Table 75. TAD Pharma Pril-series Drugs Product Offered
Table 76. TAD Pharma Pril-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. TAD Pharma Main Business
Table 78. TAD Pharma Latest Developments
Table 79. Organon Pharma Details, Company Type, Pril-series Drugs Area Served and Its Competitors
Table 80. Organon Pharma Pril-series Drugs Product Offered
Table 81. Organon Pharma Pril-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Organon Pharma Main Business
Table 83. Organon Pharma Latest Developments
Table 84. Huahai Pharmaceutical Details, Company Type, Pril-series Drugs Area Served and Its Competitors
Table 85. Huahai Pharmaceutical Pril-series Drugs Product Offered
Table 86. Huahai Pharmaceutical Pril-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Huahai Pharmaceutical Main Business
Table 88. Huahai Pharmaceutical Latest Developments
Table 89. Kunshan Rotam Reddy Pharmaceutical Details, Company Type, Pril-series Drugs Area Served and Its Competitors
Table 90. Kunshan Rotam Reddy Pharmaceutical Pril-series Drugs Product Offered
Table 91. Kunshan Rotam Reddy Pharmaceutical Pril-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Kunshan Rotam Reddy Pharmaceutical Main Business
Table 93. Kunshan Rotam Reddy Pharmaceutical Latest Developments
Table 94. Shenzhen Salubris Pharmaceuticals Details, Company Type, Pril-series Drugs Area Served and Its Competitors
Table 95. Shenzhen Salubris Pharmaceuticals Pril-series Drugs Product Offered
Table 96. Shenzhen Salubris Pharmaceuticals Pril-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Shenzhen Salubris Pharmaceuticals Main Business
Table 98. Shenzhen Salubris Pharmaceuticals Latest Developments
Table 1. Pril-series Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Pril-series Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Enalapril
Table 4. Major Players of Lisinopril
Table 5. Major Players of Captopril
Table 6. Major Players of Ramipril
Table 7. Major Players of Perindopril
Table 8. Major Players of Others
Table 9. Pril-series Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 10. Global Pril-series Drugs Market Size by Type (2019-2024) & ($ millions)
Table 11. Global Pril-series Drugs Market Size Market Share by Type (2019-2024)
Table 12. Pril-series Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 13. Global Pril-series Drugs Market Size by Application (2019-2024) & ($ millions)
Table 14. Global Pril-series Drugs Market Size Market Share by Application (2019-2024)
Table 15. Global Pril-series Drugs Revenue by Player (2019-2024) & ($ millions)
Table 16. Global Pril-series Drugs Revenue Market Share by Player (2019-2024)
Table 17. Pril-series Drugs Key Players Head office and Products Offered
Table 18. Pril-series Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Pril-series Drugs Market Size by Region (2019-2024) & ($ millions)
Table 22. Global Pril-series Drugs Market Size Market Share by Region (2019-2024)
Table 23. Global Pril-series Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 24. Global Pril-series Drugs Revenue Market Share by Country/Region (2019-2024)
Table 25. Americas Pril-series Drugs Market Size by Country (2019-2024) & ($ millions)
Table 26. Americas Pril-series Drugs Market Size Market Share by Country (2019-2024)
Table 27. Americas Pril-series Drugs Market Size by Type (2019-2024) & ($ millions)
Table 28. Americas Pril-series Drugs Market Size Market Share by Type (2019-2024)
Table 29. Americas Pril-series Drugs Market Size by Application (2019-2024) & ($ millions)
Table 30. Americas Pril-series Drugs Market Size Market Share by Application (2019-2024)
Table 31. APAC Pril-series Drugs Market Size by Region (2019-2024) & ($ millions)
Table 32. APAC Pril-series Drugs Market Size Market Share by Region (2019-2024)
Table 33. APAC Pril-series Drugs Market Size by Type (2019-2024) & ($ millions)
Table 34. APAC Pril-series Drugs Market Size by Application (2019-2024) & ($ millions)
Table 35. Europe Pril-series Drugs Market Size by Country (2019-2024) & ($ millions)
Table 36. Europe Pril-series Drugs Market Size Market Share by Country (2019-2024)
Table 37. Europe Pril-series Drugs Market Size by Type (2019-2024) & ($ millions)
Table 38. Europe Pril-series Drugs Market Size by Application (2019-2024) & ($ millions)
Table 39. Middle East & Africa Pril-series Drugs Market Size by Region (2019-2024) & ($ millions)
Table 40. Middle East & Africa Pril-series Drugs Market Size by Type (2019-2024) & ($ millions)
Table 41. Middle East & Africa Pril-series Drugs Market Size by Application (2019-2024) & ($ millions)
Table 42. Key Market Drivers & Growth Opportunities of Pril-series Drugs
Table 43. Key Market Challenges & Risks of Pril-series Drugs
Table 44. Key Industry Trends of Pril-series Drugs
Table 45. Global Pril-series Drugs Market Size Forecast by Region (2025-2030) & ($ millions)
Table 46. Global Pril-series Drugs Market Size Market Share Forecast by Region (2025-2030)
Table 47. Global Pril-series Drugs Market Size Forecast by Type (2025-2030) & ($ millions)
Table 48. Global Pril-series Drugs Market Size Forecast by Application (2025-2030) & ($ millions)
Table 49. Servier Details, Company Type, Pril-series Drugs Area Served and Its Competitors
Table 50. Servier Pril-series Drugs Product Offered
Table 51. Servier Pril-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 52. Servier Main Business
Table 53. Servier Latest Developments
Table 54. Sanofi Details, Company Type, Pril-series Drugs Area Served and Its Competitors
Table 55. Sanofi Pril-series Drugs Product Offered
Table 56. Sanofi Pril-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Sanofi Main Business
Table 58. Sanofi Latest Developments
Table 59. Novartis Details, Company Type, Pril-series Drugs Area Served and Its Competitors
Table 60. Novartis Pril-series Drugs Product Offered
Table 61. Novartis Pril-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Novartis Main Business
Table 63. Novartis Latest Developments
Table 64. Bristol-Myers Squibb Company Details, Company Type, Pril-series Drugs Area Served and Its Competitors
Table 65. Bristol-Myers Squibb Company Pril-series Drugs Product Offered
Table 66. Bristol-Myers Squibb Company Pril-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Bristol-Myers Squibb Company Main Business
Table 68. Bristol-Myers Squibb Company Latest Developments
Table 69. Pfizer Details, Company Type, Pril-series Drugs Area Served and Its Competitors
Table 70. Pfizer Pril-series Drugs Product Offered
Table 71. Pfizer Pril-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Pfizer Main Business
Table 73. Pfizer Latest Developments
Table 74. TAD Pharma Details, Company Type, Pril-series Drugs Area Served and Its Competitors
Table 75. TAD Pharma Pril-series Drugs Product Offered
Table 76. TAD Pharma Pril-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. TAD Pharma Main Business
Table 78. TAD Pharma Latest Developments
Table 79. Organon Pharma Details, Company Type, Pril-series Drugs Area Served and Its Competitors
Table 80. Organon Pharma Pril-series Drugs Product Offered
Table 81. Organon Pharma Pril-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Organon Pharma Main Business
Table 83. Organon Pharma Latest Developments
Table 84. Huahai Pharmaceutical Details, Company Type, Pril-series Drugs Area Served and Its Competitors
Table 85. Huahai Pharmaceutical Pril-series Drugs Product Offered
Table 86. Huahai Pharmaceutical Pril-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Huahai Pharmaceutical Main Business
Table 88. Huahai Pharmaceutical Latest Developments
Table 89. Kunshan Rotam Reddy Pharmaceutical Details, Company Type, Pril-series Drugs Area Served and Its Competitors
Table 90. Kunshan Rotam Reddy Pharmaceutical Pril-series Drugs Product Offered
Table 91. Kunshan Rotam Reddy Pharmaceutical Pril-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Kunshan Rotam Reddy Pharmaceutical Main Business
Table 93. Kunshan Rotam Reddy Pharmaceutical Latest Developments
Table 94. Shenzhen Salubris Pharmaceuticals Details, Company Type, Pril-series Drugs Area Served and Its Competitors
Table 95. Shenzhen Salubris Pharmaceuticals Pril-series Drugs Product Offered
Table 96. Shenzhen Salubris Pharmaceuticals Pril-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Shenzhen Salubris Pharmaceuticals Main Business
Table 98. Shenzhen Salubris Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Pril-series Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pril-series Drugs Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Pril-series Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Pril-series Drugs Sales Market Share by Country/Region (2023)
Figure 8. Pril-series Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Pril-series Drugs Market Size Market Share by Type in 2023
Figure 10. Pril-series Drugs in Hospital Pharmaty
Figure 11. Global Pril-series Drugs Market: Hospital Pharmaty (2019-2024) & ($ millions)
Figure 12. Pril-series Drugs in Retail Pharmacy
Figure 13. Global Pril-series Drugs Market: Retail Pharmacy (2019-2024) & ($ millions)
Figure 14. Global Pril-series Drugs Market Size Market Share by Application in 2023
Figure 15. Global Pril-series Drugs Revenue Market Share by Player in 2023
Figure 16. Global Pril-series Drugs Market Size Market Share by Region (2019-2024)
Figure 17. Americas Pril-series Drugs Market Size 2019-2024 ($ millions)
Figure 18. APAC Pril-series Drugs Market Size 2019-2024 ($ millions)
Figure 19. Europe Pril-series Drugs Market Size 2019-2024 ($ millions)
Figure 20. Middle East & Africa Pril-series Drugs Market Size 2019-2024 ($ millions)
Figure 21. Americas Pril-series Drugs Value Market Share by Country in 2023
Figure 22. United States Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 23. Canada Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 24. Mexico Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 25. Brazil Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 26. APAC Pril-series Drugs Market Size Market Share by Region in 2023
Figure 27. APAC Pril-series Drugs Market Size Market Share by Type (2019-2024)
Figure 28. APAC Pril-series Drugs Market Size Market Share by Application (2019-2024)
Figure 29. China Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 30. Japan Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 31. South Korea Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 32. Southeast Asia Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 33. India Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 34. Australia Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 35. Europe Pril-series Drugs Market Size Market Share by Country in 2023
Figure 36. Europe Pril-series Drugs Market Size Market Share by Type (2019-2024)
Figure 37. Europe Pril-series Drugs Market Size Market Share by Application (2019-2024)
Figure 38. Germany Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 39. France Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 40. UK Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 41. Italy Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 42. Russia Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 43. Middle East & Africa Pril-series Drugs Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Pril-series Drugs Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Pril-series Drugs Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 47. South Africa Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 48. Israel Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 49. Turkey Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 50. GCC Countries Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 51. Americas Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 52. APAC Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 53. Europe Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 54. Middle East & Africa Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 55. United States Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 56. Canada Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 57. Mexico Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 58. Brazil Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 59. China Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 60. Japan Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 61. Korea Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 62. Southeast Asia Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 63. India Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 64. Australia Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 65. Germany Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 66. France Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 67. UK Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 68. Italy Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 69. Russia Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 70. Egypt Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 71. South Africa Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 72. Israel Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 73. Turkey Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 74. GCC Countries Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 75. Global Pril-series Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 76. Global Pril-series Drugs Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Pril-series Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pril-series Drugs Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Pril-series Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Pril-series Drugs Sales Market Share by Country/Region (2023)
Figure 8. Pril-series Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Pril-series Drugs Market Size Market Share by Type in 2023
Figure 10. Pril-series Drugs in Hospital Pharmaty
Figure 11. Global Pril-series Drugs Market: Hospital Pharmaty (2019-2024) & ($ millions)
Figure 12. Pril-series Drugs in Retail Pharmacy
Figure 13. Global Pril-series Drugs Market: Retail Pharmacy (2019-2024) & ($ millions)
Figure 14. Global Pril-series Drugs Market Size Market Share by Application in 2023
Figure 15. Global Pril-series Drugs Revenue Market Share by Player in 2023
Figure 16. Global Pril-series Drugs Market Size Market Share by Region (2019-2024)
Figure 17. Americas Pril-series Drugs Market Size 2019-2024 ($ millions)
Figure 18. APAC Pril-series Drugs Market Size 2019-2024 ($ millions)
Figure 19. Europe Pril-series Drugs Market Size 2019-2024 ($ millions)
Figure 20. Middle East & Africa Pril-series Drugs Market Size 2019-2024 ($ millions)
Figure 21. Americas Pril-series Drugs Value Market Share by Country in 2023
Figure 22. United States Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 23. Canada Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 24. Mexico Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 25. Brazil Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 26. APAC Pril-series Drugs Market Size Market Share by Region in 2023
Figure 27. APAC Pril-series Drugs Market Size Market Share by Type (2019-2024)
Figure 28. APAC Pril-series Drugs Market Size Market Share by Application (2019-2024)
Figure 29. China Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 30. Japan Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 31. South Korea Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 32. Southeast Asia Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 33. India Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 34. Australia Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 35. Europe Pril-series Drugs Market Size Market Share by Country in 2023
Figure 36. Europe Pril-series Drugs Market Size Market Share by Type (2019-2024)
Figure 37. Europe Pril-series Drugs Market Size Market Share by Application (2019-2024)
Figure 38. Germany Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 39. France Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 40. UK Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 41. Italy Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 42. Russia Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 43. Middle East & Africa Pril-series Drugs Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Pril-series Drugs Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Pril-series Drugs Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 47. South Africa Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 48. Israel Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 49. Turkey Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 50. GCC Countries Pril-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 51. Americas Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 52. APAC Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 53. Europe Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 54. Middle East & Africa Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 55. United States Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 56. Canada Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 57. Mexico Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 58. Brazil Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 59. China Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 60. Japan Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 61. Korea Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 62. Southeast Asia Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 63. India Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 64. Australia Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 65. Germany Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 66. France Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 67. UK Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 68. Italy Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 69. Russia Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 70. Egypt Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 71. South Africa Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 72. Israel Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 73. Turkey Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 74. GCC Countries Pril-series Drugs Market Size 2025-2030 ($ millions)
Figure 75. Global Pril-series Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 76. Global Pril-series Drugs Market Size Market Share Forecast by Application (2025-2030)
